Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 7 of 7 clinical reviews.
A clinician-reviewed guide to medications that raise, lower, or otherwise interfere with GIP blood levels, including tirzepatide, DPP-4 inhibitors, metformin, and somatostatin analogues.
Read clinical reviewLearn what GIP does, what normal levels look like, and proven strategies to optimize gastric inhibitory polypeptide for better metabolic health, insulin sensitivity, and body composition.
Read clinical reviewLearn what your GIP (gastric inhibitory polypeptide) blood test result means, including normal ranges, high and low values, and what GIP levels reveal about metabolic health and incretin function.
Read clinical reviewCompare standard reference ranges for GIP (gastric inhibitory polypeptide) with functional optimal levels. Learn what high or low GIP means, how GIP relates to tirzepatide and incretin therapy, and when to test.
Read clinical reviewLearn what your GIP level means for GLP-1 and dual-agonist therapy. Covers normal ranges, high and low GIP, and how clinicians use this biomarker to guide tirzepatide, semaglutide, and other metabolic prescriptions.
Read clinical reviewLearn when clinicians order GIP (gastric inhibitory polypeptide) testing, what normal ranges look like, and how GIP levels connect to obesity, type 2 diabetes, and tirzepatide therapy.
Read clinical reviewA clinical guide to the lab panels you should pair with GIP testing, including GLP-1, fasting insulin, C-peptide, HbA1c, lipid panels, and hepatic function markers.
Read clinical review